Veltassa 8.4 GM powder packet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F72XB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,431
Award facts
- Contract value 100% obligated
- $1,431.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,431.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count package) on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a non-set-aside, competitively awarded contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through comprehensive supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities.
This delivery order exemplifies the operational scope of AmerisourceBergen's prime indefinite delivery vehicle with the DLA, which enables the contractor to supply pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Veltassa is a prescription medication used in the treatment of hyperkalemia (elevated potassium levels), reflecting the company's role in delivering specialized therapeutic medications across multiple clinical domains. The DLA is transitioning pharmaceutical support through its Pharmaceutical Prime Vendor Global Program Generation V initiative, which plans to establish multiple regional awards with at least three contractors, positioning AmerisourceBergen as a key participant in this modernized procurement framework.
Quick answers
Who was awarded contract SPE2DR26F72XB?
SPE2DR26F72XB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F72XB worth?
The government has obligated $1,431 on SPE2DR26F72XB.
Is contract SPE2DR26F72XB an order under another contract?
Yes. SPE2DR26F72XB is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72XB competed?
The extent of competition for SPE2DR26F72XB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award